Is pravastatin a milestone in the prevention and treatment of preeclampsia?

J Perinat Med. 2018 Oct 25;46(8):825-831. doi: 10.1515/jpm-2017-0109.

Authors

Wanda Gajzlerska-Majewska^{1

2}, Dorota A Bomba-Opon¹, Miroslaw Wielgos¹

Affiliations

¹ Medical University of Warsaw, 1st Department of Obstetrics and Gynecology, Warsaw, Poland.
² Medical University of Warsaw, Department of Drug Technology and Pharmaceutical Biotechnology, Warsaw, Poland.

PMID: 29570452
DOI: 10.1515/jpm-2017-0109

No abstract available

Publication types

Review

MeSH terms

Female
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors / adverse effects
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
Infant, Newborn
Models, Biological
Pravastatin / adverse effects
Pravastatin / therapeutic use*
Pre-Eclampsia / drug therapy*
Pre-Eclampsia / physiopathology
Pre-Eclampsia / prevention & control*
Pregnancy
Pregnancy Complications, Cardiovascular / etiology
Pregnancy Complications, Cardiovascular / physiopathology
Safety

Substances

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Pravastatin